Thu, Dec 18, 2014, 2:25 AM EST - U.S. Markets open in 7 hrs 5 mins

Recent

% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • retired_4now retired_4now Oct 7, 2013 2:49 PM Flag

    Reasons to buy

    Balance of Product Pipeline Review - 2013

    - Evaluate Celldex Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline.
    - Assess the growth potential of Celldex Therapeutics, Inc. in its therapy areas of focus.
    - Identify new drug targets and therapeutic classes in the Celldex Therapeutics, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
    - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
    - Exploit collaboration and partnership opportunities with Celldex Therapeutics, Inc..
    - Avoid Intellectual Property Rights related issues.
    - Explore the dormant and discontinued projects of Celldex Therapeutics, Inc. and identify potential opportunities in those areas.

    Sentiment: Buy

 
CLDX
18.105+1.2700(+7.54%)Dec 17 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.